Follow

Patents for monitoring medical devices has been approved in Singapore, Mexico and Japan

14 October 2020 - 15:19

Brighter’s AI patent for a system to monitor and predict wear and tear of a medical device has been approved in Singapore and Mexico. In Japan, Brighter’s patent for using a mobile device for monitoring a medical device has been approved.

“For patient-safety reasons, it is of great importance that mobile medical equipment works properly and is reliable. At the same time such devices, usually carried around by the users at all times, are likely to be exposed to a number of external stress factors such as temperature changes, humidity or chock if the user drops the device, which can cause damage. Furthermore, daily use causes general wear. It’s important for us to be able to monitor this remotely, optimally through advanced AI technology, so that we can quickly identify a potential problem and repair or replace the product in case the user hasn't noticed and reported it,” says Henrik Norström, CEO.

For further information, please contact:

Investor Relations
ir@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. 
The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

Provided by: Cision
Nasdaq First North GM (Sweden)
Brighter AB
Brighter AB develops technical and digital medical devices with a primary area of application in the treatment of diabetes. The company's Actiste products is a mobile-connected solution that can measure blood glucose, inject insulin, log treatment values, and share data over-the-air - all from the same device. Its Benefit Loop product is a cloud-based platform that links the physical collection of...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date